Israeli Researchers Develop Targeted Procedure To Destroy Myeloma Cancer In Bone Marrow

Myeloma, July 30, 2023. Under laboratory conditions, where cells are grown in flasks, the nanoparticles developed by the researchers eradicated about 90% of the cancer cells. ELLA MARU STUDIO VIA TPS.

In a groundbreaking development in the fight against myeloma, Israeli researchers have developed a targeted procedure to effectively destroy cancer within the bone marrow.

Myeloma, also known as “multiple myeloma,” is a cancer of the plasma cells, which are produced inside bone marrow. As cancer spreads within the bone marrow of myeloma patients, the body’s cells that normally produce both red and white blood cells, as well as platelets, are disrupted. White blood cells in particular play a key role in producing antibodies that protect people from infection.